酚妥拉明联合立止血治疗肺结核咯血的临床效果

Clinical Effect of Phentolamine Combined with Reptilase in Treating Hemoptysis of Pulmonary Tuberculosis

目的探究对肺结核咯血患者实行酚妥拉明联合立止血治疗所起到的干预效果。方法以2018年8月至2019年8月作为研究时段,选取我院该时段内所接纳治疗的肺结核咯血患者80例,将其采用随机分组法分为对照组(40例,垂体后叶素治疗)以及观察组(40例,酚妥拉明联合立止血治疗),对比两组患者的治疗效果。结果观察组临床治疗总有效率显著高于对照组,且不良反应发生率、止血天数明显低于对照组,差异具有统计学意义(P<0.05)。结论对肺结核咯血患者采用酚妥拉明联合立止血治疗能够保障患者疗效的提升,值得临床推广运用。

Objective To explore the intervention effect of phentolamine combined with reptilase in the treatment of pulmonary tuberculosis hemoptysis.Methods from August 2018 to August 2019 as the research period,80 cases of pulmonary tuberculosis hemoptysis patients admitted in our hospital during this period were selected and randomly divided into the control group(40 cases,pituitrin treatment)and the observation group(40 cases,phentolamine combined with reptilase treatment),compare the treatment effect of two groups of patients.Results The total effective rate of the observation group was significantly higher than that of the control group,and the incidence of adverse reactions and hemostasis days were significantly lower than that of the control group,the difference was statistically significant(P<0.05).Conclusion In the treatment of patients with pulmonary tuberculosis hemoptysis,phentolamine combined with reptilase can ensure the improvement of the curative effect of patients,so it is worthy of clinical application.